Active Pharmaceutical Ingredients (APIs), once considered a backend component of drug production, are now emerging as ...

The Europe pharmaceutical CDMO market size is calculated at USD 37.98 billion in 2025 and is expected to reach around USD ...

A recent executive order signed by President Donald Trump calls for the government to build a Strategic Active Pharmaceutical Ingredients Reserve ...

DUBLIN--(BUSINESS WIRE)--The "United States Active Pharmaceutical Ingredients Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2024" report has been added to ...

AbbVie (ABBV) announced the start of construction of its new active pharmaceutical ingredient manufacturing plant in North ...

The alignment of President Trump’s remarks with RFK Jr.’s longstanding support for plant-based medicines highlights the ...

Pharmaceutical contract manufacturing and API sourcing in Central Europe and the Balkan states 2011 is the latest report providing an in-depth analysis for pharmaceutical contract manufacturing and ...

Get 30% Off All Global Market Reports With Code ONLINE30 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors” - The Business Research Company LONDON, GREATER LONDON, UNITED ...

HOUSTON — Eli Lilly and Co. (NYSE: LLY) has unveiled plans to build a new $6.5 billion manufacturing facility at Generation ...

The convergence of biopharmaceutical innovation, contract manufacturing partnerships, and advanced synthesis technologies is redefining how drugs are developed, manufactured, and delivered worldwide N ...